Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol
The role of glucagon-like peptide 1 (GLP-1) in insulin-dependent signaling is well-known; GLP-1 enhances glucose-dependent insulin secretion and lowers blood glucose in diabetes. GLP-1 receptors (GLP-1R) are also widely expressed in the brain, and in addition to its role in neuroprotection, it affec...
Main Authors: | Candan Yasemin Eren-Yazicioglu, Arya Yigit, Ramazan Efe Dogruoz, Hale Yapici-Eser |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Behavioral Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnbeh.2020.614884/full |
Similar Items
-
The central GLP-1: implications for food and drug reward
by: Karolina Patrycja Skibicka
Published: (2013-10-01) -
Mood Fluctuation and Psychobiological Instability: The Same Core Functions Are Disrupted by Novel Psychoactive Substances and Established Recreational Drugs
by: Andrew C. Parrott
Published: (2018-03-01) -
Psychostimulant Drugs and Neuroplasticity
by: Emilio Fernandez-Espejo, et al.
Published: (2011-06-01) -
Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo
by: Paul J. Fitzgerald
Published: (2021-10-01) -
Retrospective analysis of stimulant abuse cases reported to the Swiss Toxicological Information Centre during 1997–2009
by: M Bruggisser, et al.
Published: (2010-10-01)